Prospector Partners LLC Increases Stake in Option Care Health, Inc. $OPCH

Key Points

• Prospector Partners LLC has increased its stake in Option Care Health by 22.9%, now owning approximately 111,200 shares valued at around $3.9 million.
• In the first quarter, other investors such as Versor Investments LP and Raymond James Financial Inc. also significantly increased their holdings in Option Care Health.
• Option Care Health reported a quarterly earnings per share of $0.41, exceeding analysts' expectations, with a revenue of $1.42 billion.

Prospector Partners LLC boosted its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 22.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 111,200 shares of the company's stock after purchasing an additional 20,700 shares during the period. Prospector Partners LLC owned about 0.07% of Option Care Health worth $3,886,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of the stock. Versor Investments LP increased its stake in Option Care Health by 191.8% in the 1st quarter. Versor Investments LP now owns 56,900 shares of the company's stock worth $1,989,000 after purchasing an additional 37,400 shares during the period. Raymond James Financial Inc. increased its stake in shares of Option Care Health by 110.7% during the first quarter. Raymond James Financial Inc. now owns 184,074 shares of the company's stock valued at $6,433,000 after buying an additional 96,719 shares during the period. Cresset Asset Management LLC purchased a new position in shares of Option Care Health during the first quarter valued at approximately $300,000. Fox Run Management L.L.C. increased its stake in shares of Option Care Health by 30.0% during the first quarter. Fox Run Management L.L.C. now owns 26,999 shares of the company's stock valued at $944,000 after buying an additional 6,238 shares during the period. Finally, Cookson Peirce & Co. Inc. purchased a new position in shares of Option Care Health during the first quarter valued at approximately $837,000. 98.05% of the stock is owned by hedge funds and other institutional investors.

Option Care Health Trading Down 0.3%

Shares of NASDAQ:OPCH opened at $28.32 on Monday. The company has a market cap of $4.60 billion, a P/E ratio of 22.66, a PEG ratio of 1.79 and a beta of 0.79. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.52 and a quick ratio of 1.00. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $35.53. The stock's fifty day moving average price is $30.29 and its 200-day moving average price is $31.86.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.40 by $0.01. The firm had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.35 billion. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%. The company's quarterly revenue was up 15.4% on a year-over-year basis. During the same period in the prior year, the company posted $0.30 earnings per share. Sell-side analysts expect that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the company. JMP Securities boosted their target price on Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a research note on Thursday, July 31st. Barrington Research reissued an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a research note on Thursday, July 10th. UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and upped their price target for the stock from $38.00 to $40.00 in a research note on Wednesday, April 30th. Finally, Citigroup reaffirmed an "outperform" rating on shares of Option Care Health in a research note on Thursday, July 31st. One research analyst has rated the stock with a hold rating and eight have issued a buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $35.75.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.